Table A7.
Sample ID | ESBL | Ampicillin | Ampicillin/Sulbactam | Piperacillin/Tazobactam | Cefuroxime | Cefuroxime Axetil | Cefpodoxime | Cefotaxime | Ceftrazidime | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | ||
41 | positive | ≥32 | R | ≥32 | R | 64 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
49 | negative | ≥32 | R | 16 | R | ≤4 | S | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
68 | negative | ≥32 | R | 16 | R | ≤4 | S | ≤1 | I | ≤1 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
117 | negative | ≥32 | R | ≥32 | R | 64 | R | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
152 | negative | ≥32 | R | ≥32 | R | ≥128 | R | 4 | I | 4 | S | 0.5 | S | ≤1 | S | ≤1 | S |
176 | negative | ≥32 | R | ≥32 | R | ≤4 | I | 2 | I | 2 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
221 | negative | ≥32 | R | ≥32 | R | ≤4 | I | 2 | I | 2 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
222 | negative | ≥32 | R | ≥32 | R | ≤4 | I | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |
225 | positive | ≥32 | R | ≥32 | R | ≤4 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | 16 | R |
245 | positive | ≥32 | R | ≥32 | R | 16 | I | 16 | R | 16 | R | 1 | S | 2 | I | ≤1 | S |
270 | positive | ≥32 | R | 16 | R | ≤4 | R | ≥64 | R | ≥64 | R | ≥8 | R | ≥64 | R | ≥64 | R |
299 | negative | ≥32 | R | ≤2 | I | ≤4 | S | 4 | I | 4 | S | ≤0.25 | S | ≤1 | S | ≤1 | S |